EUVIMEDEUVIMED entdecken
Crossref

Addendum: Urinary Incontinence with Second-Generation Antipsychotic Drugs

The Medical Letter on Drugs and Therapeutics · 02.03.2026 · 68 (1749) · 40-40

DOI: 10.58347/tml.2026.1749c ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, online erschienen am 02.03.2026.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our recent article entitled Lumateperone (Caplyta) for Adjunctive Treatment of Depression1 should have included urinary incontinence among the adverse effects associated with use of second-generation antipsychotic drugs. Urinary incontinence has been reported with both first- and second-generation antipsychotics. Possible causes include the anti-alpha-adrenergic, antidopaminergic, and anticholinergic effects of these drugs, as well as sedation. In an observational study in 200 women 20-40 years old, urinary incontinence was reported by 29% of those taking antipsychotic drugs and by 13% of age-matched controls.

Schlagwörter

Stichwörter der Autor:innen

Caplytaadverse effectsantipsychoticsdepressionlumateperonesafety

Zitieren

APA

(2026). Addendum: Urinary Incontinence with Second-Generation Antipsychotic Drugs. The Medical Letter on Drugs and Therapeutics, 68(1749), 40-40. https://doi.org/10.58347/tml.2026.1749c

Vancouver

Addendum: Urinary Incontinence with Second-Generation Antipsychotic Drugs. The Medical Letter on Drugs and Therapeutics. 2026;68(1749):40-40. doi:10.58347/tml.2026.1749c

BibTeX
@article{euvimed2026,
  title = {Addendum: Urinary Incontinence with Second-Generation Antipsychotic Drugs},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2026},
  volume = {68},
  number = {1749},
  pages = {40--40},
  doi = {10.58347/tml.2026.1749c}
}
Kostenlos starten →